Montreal, Canada: Canadian patients authorized to use medical cannabis products report sustained improvements in their health-related quality of life, according to longitudinal data published in the journal Cannabis and Cannabinoid Research. A team of investigators affiliated with McGill University in Montreal assessed the safety and efficacy of medical cannabis products in a cohort of 2,991 patients. Subjects in the study consumed cannabis flower, extracts, …
New Orleans, LA: The administration of plant-derived THC is associated with reductions in agitation and other behavioral issues in a patient with dementia, according to a case report published in the Journal of Palliative Medicine. Researchers affiliated with Tulane University’s School of Medicine and the University of Texas reported on the use of a THC-dominant tincture in an 85-year-old dementia patient. The subject exhibited …
Washington, DC: Nearly one in three patients with chronic pain use cannabis as an analgesic agent, and many of those who do substitute in place of opioids, according to data published today in the journal JAMA Network Open. Researchers with the University of Michigan at Ann Arbor and the Johns Hopkins School of Public Health in Baltimore surveyed 1,724 adults suffering from chronic pain conditions who …
Modena, Italy: The administration of a topical extract preparation of CBD effectively mitigates wound-related pain and promotes the healing of skin ulcers in patients with scleroderma, according to randomized trial data published in the journal Advances in Skin & Wound Care. Scleroderma (a/k/a systemic sclerosis) is a rare autoimmune disorder involving the tightening of the skin and the narrowing of blood vessels. Italian investigators assessed the …
London, United Kingdom: The daily consumption of cannabis products is associated with sustained improvements in depressive symptoms, according to observational trial data published in the journal Expert Review of Neurotherapeutics. British investigators assessed the safety and efficacy of cannabis products in 129 subjects with a primary diagnosis of depression. Study subjects were participants in the UK Medical Cannabis Registry and all possessed a doctor’s authorization to …
Toronto, Canada: Cannabis compounds are effective at mitigating chronic neuropathic pain and improving sleep, according to a review of randomized controlled trial data published in the journal Regional Anesthesia & Pain Medicine. A team of Canadian researchers evaluated results from nine trials that compared synthetic and natural cannabinoids to placebo in patients suffering from neuropathic pain syndromes. They reported: “Meta-analysis of data from six …
LONGMONT, Colo., Jan. 5, 2023 /PRNewswire/ — Trilogene Seeds announces advanced cannabis research. The team is at the validation stage of developing a NGS solution for cannabis genetic improvement with the aim of accurately targeting genes of interest and accelerating breeding for commercial cannabis cultivation. The diecious nature of cannabis contributes to the high heterozygosity, which makes genetic stabilization for cultivation complicated, …
SAN FRANCISCO & HILLSBORO, Ore.–(BUSINESS WIRE)–Portland State University’s Department of Chemistry, PAX, a leading global cannabis brand delivering well-being through exceptional cannabis experiences, and True Terpenes, an innovative terpene solutions platform delivering true-to-experience flavors and aromas under the industry’s strictest standards for safety and compliance, today announced that their joint paper titled A First-Tier Framework for Assessing Toxicological Risk from Vaporized Cannabis Concentrates has …
Melbourne, Australia: The short-term use of plant-derived cannabis extracts is well-tolerated and effective in patients diagnosed with insomnia, according to placebo-controlled trial data published in the Journal of Sleep Research. Australian researchers assessed the use of a proprietary cannabis oil product (Entoura-10:15) versus placebo in 29 subjects with chronic insomnia. Extracts contained 10mg of THC and 15mg of CBD. Participants consumed either extracts or …
Fairfield, CA: The inhalation of cannabis flowers is effective and well-tolerated among patents with migraine, according to a systematic review of the literature published in the journal Cureus. A team of researchers affiliated with the California Institute of Behavioral Neurosciences and Psychology reviewed nine recent studies involving over 5,600 subjects. They reported: “All the studies showed encouraging findings on the therapeutic effects of medicinal …